SAREPTA THERAPEUTICS INC (SRPT)

US8036071004 - Common Stock

128.77  +1.38 (+1.08%)

After market: 128.77 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
701.9M
29.96%		933M
32.92%		1.243B
33.26%		1.901B
52.90%
EBITDA
YoY % growth
-411.7M
23.38%		-494.3M
-20.06%		-223.427M
54.80%		89.755M
140.17%		N/AN/AN/AN/A
EBIT
YoY % growth
-449.7M
20.29%		-536.2M
-19.24%		-267.824M
50.05%		187.22M
169.90%
Operating Margin
-64.07%-57.47%-21.54%9.85%
EPS
YoY % growth
-6.01
7.40%		-8.03
-33.61%		-6.12
23.79%		2.50
140.86%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.07
98.77%
Revenue
Q2Q % growth		380.75M
50.20%
EBITDA
Q2Q % growth		-17.034MN/AN/AN/AN/A
EBIT
Q2Q % growth		-14.49M
89.51%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.47
137.90%		0.020.453,019.73%
Q3 2023
Q2Q % growth		 -0.46
84.35%		-1.260.8063.36%
Q2 2023
Q2Q % growth		 -0.27
89.81%		-1.811.5485.10%
Q1 2023
Q2Q % growth		 -5.86
-388.33%		-1.41-4.45-315.34%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 396.781M
53.55%		394.03M2.751M0.70%
Q3 2023
Q2Q % growth		 331.8M
44.07%		291.04M40.76M14.00%
Q2 2023
Q2Q % growth		 261.2M
11.86%		264.74M-3.54M-1.34%
Q1 2023
Q2Q % growth		 253.5M
20.26%		246.79M6.71M2.72%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-43.65% -106.48% -0.84% -17.19%
Revenue-0.77% -8.65% 0.37% -1.45%